Skip to main content
Back to news homepage

RCOG announcement: New Fellows ad eundem announced today

News 26 September 2014

This afternoon the Royal College of Obstetricians and Gynaecologists (RCOG) recognises international figures who have a made a significant contribution to women’s health.

The Fellows’ Admission ceremony this afternoon saw the admission of seven new Fellows ad eundem from all over the world.

Fellow ad eundem is awarded to persons who are not members of the College and who have contributed to the advancement of the science or practice of obstetrics and gynaecology who the RCOG Council considers to have furthered the interests of the specialty.

More information about the new Fellows can be found below:

Professor Luca Gianaroli, Italy

Professor Luca Gianaroli has played an immensely influential role in the continuing development of the European Society of Human Reproduction and Embryology (ESHRE).

His contribution to scientific research and understanding of human embryology has been at the forefront of cutting edge technology. The most recent example of his innovation was the EU multicentre ESTEEM study of CGH (comparative genomic hybridisation) analysis of oocyte polar body biopsy to exclude aneuploidy prior to fertilisation and embryo transfer.

Professor Steven Goldstein, United States of America

Through his interest in gynaecological ultrasonography, clinical observations and ability to teach, explain and help test those observations, Professor Steven Goldstein has helped change how gynaecology is practised.

Steven’s contribution to the ACOG’s Green Journal marks a cornerstone in evaluating uterine bleeding, by utilising transvaginal ultrasound rather than blind endometrial sampling. He changed how we view endometrial fluid collections found on transvaginal ultrasound in postmenopausal women.

Dr Stephen Lye, Canada

Dr Stephen Lye is internationally recognised for his scientific contributions in the fields of preterm labour, pre-eclampsia and the Developmental Origins of Health and Disease (DOHaD).

Dr Lye has demonstrated a profound commitment to the advancement of obstetrics and gynaecology both locally and internationally and has served as a member of the Advisory Board of the CIHR Institute of Human Development, Child and Youth Health. His career has been dedicated to the discovery of knowledge that will improve the health of mothers and children by promoting interdisciplinary understanding.

Professor François Nosten, Thailand

Professor Nosten is part of the Wellcome Trust’s South East Asia programme which is carrying out research to facilitate the improvement of the diagnosis, management and prevention of important tropical diseases through the understanding of their pathogenesis, pathophysiology, genetics and epidemiology.

The research conducted by Professor Nosten’s team includes trials into the prevention and optimal treatment of malaria as well as studying the pharmacokinetics of treatments in pregnant women, an area with minimal previous research.

Dr Allan Pacey, England

For the last twenty years Dr Pacey has been a major figure in the British Fertility Society (BFS). He has regularly contributed to the work of the College.

Allan has made a major contribution to the public understanding of our profession through his work with the media. This includes through newspapers, radio and various television programmes where he has been able to clearly explain complex aspects of medical science, as well as raise the debate and counter critics of controversial topics.

Allan is a research scientist working at the interface between the laboratory and clinical practice. His research in andrology has had a major impact on women’s health by investigating infertility in males.

Professor Neil J Sebire, England

Professor Neil Sebire spent his postgraduate training in O&G at St Mary’s Hospital, London and his MD in fetal medicine at King’s College Hospital which resulted in several landmark publications documenting the mortality of monochorionic twin pregnancies, early detection of twin to twin transfusion syndrome and nuchal translucency screening in twins. He was the first to quantify the increased risk of adverse pregnancy outcomes in obese woman.

He has contributed to the advancement of the specialty, with particular emphasis on bringing together the clinical aspects and pathological basis of diseases in pregnancy and the fetus through significant research and has published over 400 peer reviewed papers.

Professor Dirk Timmerman, Belgium

Professor Dirk Timmerman is a clinical researcher with a national and international reputation. He is the founder and coordinator of the International Ovarian Tumour Analysis (IOTA) collaborative group which has developed new algorithms to detect ovarian cancer.

These algorithms have been incorporated into protocols around the world including the RCOG Green-top Guidelines.